Delaware Valley Node of the Clinical Trials Network
临床试验网络特拉华谷节点
基本信息
- 批准号:7386428
- 负责人:
- 金额:$ 33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:10pAIDS preventionAIDS/HIV problemARHGEF5 geneAccountingAccreditationAchievementAcquired Immunodeficiency SyndromeAddendumAddressAdherenceAdministratorAdmission activityAdolescentAdoptedAdoptionAdultAdvisory CommitteesAdvocateAffectAfricanAfrican AmericanAgeAge-YearsAgonistAgreementAlcohol dependenceAlcohol or Other Drugs useAlcoholismAll SitesAltitudeAmendmentAmericanAncillary StudyAntidepressive AgentsAntiviral AgentsAppendixApplications GrantsAppointmentAreaArtsAsiansAttentionAttitudeAwardBackBaltimoreBaseline SurveysBehaviorBehavior TherapyBehavioralBeliefBiologicalBiological PsychiatryBoard CertificationBoxingBrazilBudgetsBuprenorphineBusinessesCPDD protocolCalculiCaringCensusesCharacteristicsChargeChildChronic DiseaseCitiesClassificationClergyClientClinicClinicalClinical DataClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkClinical Trials, OtherClonidineCocaineCocaine DependenceCodeCognitiveCognitive TherapyCollaborationsCommunicable DiseasesCommunicationCommunitiesCommunity Health EducationCommunity ParticipationComputer softwareConditionConduct Clinical TrialsConflict (Psychology)ConsensusConsentConsultConsultationsContractorContractsControlled Clinical TrialsCopyrightCost Effectiveness AnalysisCost SavingsCosts and BenefitsCounselingCountCountryCountyCriminal JusticeCustomDSM-IVDSM-VDataData AnalysesData CollectionDatabasesDay CareDelawareDepressed moodDepthDetoxDevelopmentDiabetes MellitusDiagnosisDiagnosticDictionaryDiffusion of InnovationDiseaseDistressDoctor of MedicineDoctor of PhilosophyDocumentationDoseDropoutDropsDrug AddictionDrug CourtsDrug Metabolic DetoxicationDrug abuseDrug usageDryopteris filix-masEducationEducational process of instructingEffectivenessEffectiveness of InterventionsElectronic MailElectronicsElementsEligibility DeterminationEmployeeEnrollmentEnsureEquilibriumEquipmentEquipment and SuppliesEthnic OriginEvaluationEventEvidence based interventionEvidence based practiceExclusion CriteriaExperimental DesignsExploratory/Developmental Grant for Diagnostic Cancer ImagingFacultyFamily psychotherapyFee-for-Service PlansFeedbackFeesFemaleFinancial SupportFloridaFoodFosteringFoundationsFrequenciesFriendsFundingFunding AgencyFutureGenderGeneral HospitalsGenerationsGeneric DrugsGenesGeneticGoalsGrantGuidelinesHIVHIV InfectionsHIV prevention trials networkHIV vaccineHalfway HousesHallucinogensHeadHealthHealth PersonnelHealth ServicesHealth Services ResearchHealth systemHealthcareHearingHepatitis CHeroinHeroin DependenceHeterosexualsHispanicsHomelessnessHomosexualsHornsHospitalizationHospitalsHourHouseholdHousingHuman ResourcesHybridsHylobates GenusHypertensionIceIncentivesIncidenceIndividualIndustryInfectionInformaticsInformation SystemsInjection of therapeutic agentInpatientsInstitute of Medicine (U.S.)InstitutesInsuranceInterest GroupInternationalInternetInterventionInterviewInterviewerIntravenousInvestigationJoint Commission on Accreditation of Healthcare OrganizationsJournalsKnowledgeLeadLeadershipLearningLeftLettersLibrariesLicensingLife StyleLiteratureLocationLong IslandMaineMaintenanceManualsManuscriptsMarijuanaMarketingMarylandMeasurementMeasuresMediationMedicalMedical StudentsMedical centerMedicineMental DepressionMental HealthMental disordersMentorsMethadoneMethadyl AcetateMethodsMindMinorityMissionModalityModelingModificationMonitorMothersMulti-Institutional Clinical TrialNaloxoneNaltrexoneNamesNational Institute of Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNeurologyNew EnglandNew JerseyNew MexicoNewsletterNicotineNone or Not ApplicableNumbersNursesNutsOccupationsOnline SystemsOperations ResearchOperative Surgical ProceduresOpiate AddictionOpiatesOpioidOregonOrganizational PolicyOther FindingOutcomeOutpatientsPainPaperParentsParticipantPatient Self-ReportPatientsPediatric HospitalsPeer ReviewPennsylvaniaPerformancePersonal CommunicationPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacological TreatmentPharmacologyPharmacotherapyPhasePhiladelphiaPhysician ExecutivesPhysiciansPilot ProjectsPlaguePlayPoliciesPopulationPositioning AttributePre-studyPregnant WomenPreparationPresbyterian ChurchPreventionPrevention educationPrevention interventionPrimary Health CarePrincipal InvestigatorProceduresProcessProfessional counselorProgress ReportsPropoxypheneProtocol ComplianceProtocols documentationProviderPsyche structurePsychiatric DiagnosisPsychiatristPsychiatryPsychotherapyPublic HealthPublic OpinionPublicationsPublished CommentPublishingPurposeQualifyingRaceRandomizedRandomized Controlled Clinical TrialsRangeRateReadinessReadingRecording of previous eventsRecordsRecoveryRecruitment ActivityRegistered nurseRegulationRegulatory AffairsRehabilitation therapyRelapseReportingResearchResearch ActivityResearch DesignResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch TrainingResolutionResourcesRestReview, Systematic (PT)RiotsRiskRisk AssessmentRisk BehaviorsRisk FactorsRisk ReductionRoleRunningRuralRussiaSafetySamplingScheduleSchoolsScienceScreening procedureSenior Scientist AwardSeriesServicesSeveritiesShelter facilitySiteSleep DisordersSlideSolidSolutionsSorbusSourceSpecific qualifier valueSpiritualityStagingStandards of Weights and MeasuresStigmataStreamStructureStudentsStudy SectionSubgroupSubstance Use DisorderSubstance abuse problemSuggestionSupervisionSurveysSymptomsSystemTNFRSF11B geneTechnologyTechnology TransferTelephoneTestingTextTherapeuticTherapeutic InterventionTherapeutic community techniqueThinkingTimeTitleTodayTrainers TrainingTrainingTraining and EducationTraumaTravelTreatment CostTreatment EfficacyTreatment ProtocolsTreatment outcomeUSA GeorgiaUnited States Department of Veterans AffairsUnited States Food and Drug AdministrationUnited States National Academy of SciencesUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services AdministrationUniversitiesUnsafe SexUpdateVaccinesVaginaVeteransVisitVoiceVotingVulnerable PopulationsWashingtonWeekWestern Asia GeorgiaWineWomanWomen&aposs GroupWood materialWorkWritingYouthaddictionadolescent smokingalcohol and other drugalcohol effectantiretroviral therapyauthoritybasebeanbehavioral healthcapitate bonecareerclinical research siteclinically relevantcollegecomparativecompliance behaviorconceptcontingency managementcookingcooperative studycostcost effectivecost effectivenessdata integritydata managementdaydesigndisorder riskdrug of abusedrug standardeditorialexpectationexperiencefallsfightingfollow-uphuman subjectimprovedindexinginfancyinner cityinnovationinsightinstrumentinterestlectureslenslocustmalemalignant breast neoplasmmedical schoolsmembermenmen who have sex with menmen&aposs groupmethadone clinic/centermodel designmotivational enhancement therapyneglectneuroimagingneurosurgerynewsorganizational structureoutreach programpaymentprescription documentprescription procedureprofessorprogramsprotocol developmentpsychosocialquality assuranceresearch and developmentresearch studyresponsesafer sexsatisfactionsimulationsizeskillssmoking cessationsocialsocial stigmasuccesssymposiumtau Proteinstooltreatment centertreatment programtreatment sitevolunteerwillingnessyoung adult
项目摘要
The PI, Co-Pi, Key Personnel and other staff of the Delaware Valley Node (DVN) have substantial breadth and
depth of experience in treating persons with substance use disorders and carrying out clinical trials involving
pharmacologic, behavioral, and health services research, as well as studies focusing on HIV, genetics, and
neuroimaging. This application responds to the specific requirements of the RFA by presenting the DVN capabilities in
three parts: Part A is a Description of the DVN including how it contributes to the overall goals of the CTN;
information about faculty, staff, and community treatment providers (CTPs); an organizational chart illustrating its
management structure; and a narrative describing how our organizational components work to implement multi-site
trials and disseminate evidence-based practices. The DVN draws upon the considerable strengths of the University of
Pennsylvania, the Treatment Research Institute, and leading CTPs from Pennsylvania, New Jersey and Delaware.
Importantly, all DV Node CTPs have experience and enthusiasm as practice/research partners. To strengthen our
ability to implement studies related to HIV and other infectious diseases, two infectious disease clinics (IDCs) have
been added to the DVN. Part B is a Progress Report with a summary of accomplishments over the past five years
including: enrollment data for all CTN protocols, ancillary studies, and platform studies in which the DVN participated.
The ten research concepts proposed by the DV Node are presented, followed by a summary of two protocols the DVN
was approved to lead. The procedures employed in these protocols, specific lessons learned, and contributions that
resulted are briefly described. Our contributions to the CTN infrastructure and its ongoing management are
summarized, along with a description of the DVN's training, education, dissemination, and technology transfer
activities. Part C is a Research Concept entitled "Integrating Substance Abuse Treatment into Infectious Disease
Clinics." It proposes to test two models for treating individualswho have HIV or HepC and receive antiviral treatment
in Infectious Disease Clinics (IDCs): integrated substance abuse treatment onsite at the IDC; or referral to a nearby!
substance abuse program, which is treatment as usual. Primary outcomes are reduction in substance use, reduction in
HIV risk behavior, and compliance with antiviral treatment. If accepted by the CTN with positive results, the findings
could reduce substance use and improve the outcome of treatment for persons with substance use disorders who have
HIV and HepC, and reduce behaviors that spread HIV and other infectious diseases.
特拉华州山谷节点(DVN)的PI、Co-PI、关键人员和其他工作人员具有相当的广度,
在治疗物质使用障碍患者和开展临床试验方面的丰富经验,
药理学、行为学和卫生服务研究,以及侧重于艾滋病毒、遗传学和
神经成像此应用程序通过在以下文件中提供DVN功能来响应RFA的特定要求:
三个部分:A部分是对DVN的描述,包括它如何对CTN的总体目标做出贡献;
有关教师,工作人员和社区治疗提供者(CTPs)的信息;说明其组织结构图
管理结构;以及描述我们的组织组件如何工作以实现多站点的叙述
试验和传播循证实践。该DVN借鉴了大学的相当大的优势,
宾夕法尼亚州,治疗研究所,以及来自宾夕法尼亚州,新泽西和特拉华州的领先CTP。
重要的是,所有DV Node CTP都有作为实践/研究合作伙伴的经验和热情。加强我们
有能力实施与艾滋病毒和其他传染病有关的研究,两个传染病诊所(IDC)
已添加到DVN。B部分是一份进度报告,总结了过去五年的成就
包括:DVN参与的所有CTN方案、辅助研究和平台研究的入组数据。
首先介绍了DV Node提出的10个研究概念,然后对DVN两个协议进行了总结
被批准领导。这些议定书中采用的程序、吸取的具体经验教训以及
结果进行了简要描述。我们对CTN基础设施及其持续管理的贡献如下:
总结,并沿着对国防部虚拟网络的培训、教育、传播和技术转让的描述
活动C部分是题为“将药物滥用治疗纳入传染病”的研究概念
诊所。“它建议测试两种模型来治疗患有HIV或HepC并接受抗病毒治疗的个体
传染病诊所(IDC):在IDC现场进行综合药物滥用治疗;或转诊至附近!
药物滥用项目,也就是常规治疗。主要成果是减少物质使用,减少
HIV危险行为和抗病毒治疗依从性。如果CTN接受了阳性结果,
可以减少物质使用并改善患有物质使用障碍的人的治疗结果,
HIV和HepC,并减少传播HIV和其他传染病的行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE Edward WOODY其他文献
GEORGE Edward WOODY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE Edward WOODY', 18)}}的其他基金
Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone
阿片类药物复发
- 批准号:
8717625 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone
阿片类药物复发
- 批准号:
8519398 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone
阿片类药物复发
- 批准号:
9116813 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone
阿片类药物复发
- 批准号:
8310620 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
海洛因成瘾者对艾滋病毒治疗的依从性:口服纳曲酮与缓释纳曲酮
- 批准号:
7756239 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Suboxone and Methadone for HIV Risk Reduction in Subutex Injectors
Suboxone 和美沙酮可降低 Subutex 注射器中的 HIV 风险
- 批准号:
7684519 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
海洛因成瘾者对艾滋病毒治疗的依从性:口服纳曲酮与缓释纳曲酮
- 批准号:
8143927 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
海洛因成瘾者对艾滋病毒治疗的依从性:口服纳曲酮与缓释纳曲酮
- 批准号:
8092869 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
海洛因成瘾者对艾滋病毒治疗的依从性:口服纳曲酮与缓释纳曲酮
- 批准号:
8298404 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone
海洛因成瘾者对艾滋病毒治疗的依从性:口服纳曲酮与缓释纳曲酮
- 批准号:
8288300 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
相似海外基金
HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
- 批准号:
495195 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10013921 - 财政年份:2020
- 资助金额:
$ 33万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10181081 - 财政年份:2020
- 资助金额:
$ 33万 - 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
- 批准号:
10166309 - 财政年份:2020
- 资助金额:
$ 33万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10597008 - 财政年份:2020
- 资助金额:
$ 33万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10386931 - 财政年份:2020
- 资助金额:
$ 33万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9921510 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9753631 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
10265667 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
- 批准号:
364681 - 财政年份:2017
- 资助金额:
$ 33万 - 项目类别: